After inputting your patient’s information into this tool, an individual administration schedule will be generated. This is a detailed plan for your patient, which outlines the dose and timing of QARZIBA® along with the pre- and concomitant medications, allowing you to be confident in the treatment course that lies ahead.
Recordati Rare Diseases is committed to providing tools and resources that support your patients’ treatment journey with QARZIBA®, and the QARZIBA® dosing calculator is just one example of our dedication to advancing paediatric cancer care.
Access the dosing calculator below:
GL-QAR-0144 | June 2024
GL-QAR-0145 | June 2024
Reference
- QARZIBA® (dinutuximab beta). Summary of product characteristics.
This is a promotional website created by Recordati Rare Diseases and is intended for HCPs only.